Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Trial Profile

Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Modafinil (Primary)
  • Indications Fatigue; Primary biliary cirrhosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Jun 2016 New trial record
    • 04 May 2016 Primary endpoint of change in fatigue severity (quantified by the FFIS) has not been met, according to results published in the American Journal of Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top